Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.38 USD | -2.50% | +1.60% | +16.05% |
May. 08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
May. 07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.05% | 3.21B | |
+33.40% | 49.46B | |
+1.63% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.60% | 26.61B | |
-22.78% | 18.64B | |
+8.09% | 13.16B | |
+29.19% | 12.55B | |
+24.33% | 12.1B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- RBC Raises Price Target on IDEAYA Biosciences to $36 From $32, Keeps Outperform Rating, Speculative Risk Qualifier